Clinical Trial Update: A Trial to Compare the Efficacy, Safety and Tolerability of Combinations of 3 Anti-malarial Drugs Against Combina-tions of 2 Anti-malarial Drugs. [Phase 3]

View source ↗

Summary

A Phase 3 trial sponsored by the University of Oxford comparing three-drug anti-malarial combinations to two-drug regimens for uncomplicated Plasmodium falcipar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uncomplicated Plasmodium Falciparum Malaria

Snippet

Sponsor: University of Oxford | Conditions: Plasmodium Falciparum Malaria (Uncomplicated) | Phase 3 | Status: COMPLETED